CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial
Authors
C Arnott
G Bakris
+12Â more
CP Cannon
DM Charytan
HJL Heerspink
M Jardine
A Levin
KW Mahaffey
B Neal
BL Neuen
M Oshima
V Perkovic
C Pollock
DC Wheeler
Publication date
1 October 2021
Publisher
OXFORD UNIV PRESS
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
UNSWorks
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:unsworks.library.unsw.edu....
Last time updated on 15/05/2024
